239 related articles for article (PubMed ID: 15611135)
41. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B.
Jia Z; Barford D; Flint AJ; Tonks NK
Science; 1995 Jun; 268(5218):1754-8. PubMed ID: 7540771
[TBL] [Abstract][Full Text] [Related]
42. Structural basis for the preference of the
Labandera AM; Uhrig RG; Colville K; Moorhead GB; Ng KKS
Sci Signal; 2018 Apr; 11(524):. PubMed ID: 29615518
[TBL] [Abstract][Full Text] [Related]
43. Mutational analysis of the tyrosine phosphatome in colorectal cancers.
Wang Z; Shen D; Parsons DW; Bardelli A; Sager J; Szabo S; Ptak J; Silliman N; Peters BA; van der Heijden MS; Parmigiani G; Yan H; Wang TL; Riggins G; Powell SM; Willson JK; Markowitz S; Kinzler KW; Vogelstein B; Velculescu VE
Science; 2004 May; 304(5674):1164-6. PubMed ID: 15155950
[TBL] [Abstract][Full Text] [Related]
44. Structural basis for the recognition of a bisphosphorylated MAP kinase peptide by human VHR protein Phosphatase.
Schumacher MA; Todd JL; Rice AE; Tanner KG; Denu JM
Biochemistry; 2002 Mar; 41(9):3009-17. PubMed ID: 11863439
[TBL] [Abstract][Full Text] [Related]
45. Redox-regulated affinity of the third PDZ domain in the phosphotyrosine phosphatase PTP-BL for cysteine-containing target peptides.
van den Berk LC; Landi E; Harmsen E; Dente L; Hendriks WJ
FEBS J; 2005 Jul; 272(13):3306-16. PubMed ID: 15978037
[TBL] [Abstract][Full Text] [Related]
46. Structure-guided studies of the SHP-1/JAK1 interaction provide new insights into phosphatase catalytic domain substrate recognition.
Alicea-Velázquez NL; Jakoncic J; Boggon TJ
J Struct Biol; 2013 Mar; 181(3):243-51. PubMed ID: 23296072
[TBL] [Abstract][Full Text] [Related]
47. Allosteric inhibition of protein tyrosine phosphatase 1B.
Wiesmann C; Barr KJ; Kung J; Zhu J; Erlanson DA; Shen W; Fahr BJ; Zhong M; Taylor L; Randal M; McDowell RS; Hansen SK
Nat Struct Mol Biol; 2004 Aug; 11(8):730-7. PubMed ID: 15258570
[TBL] [Abstract][Full Text] [Related]
48. Regulation of TRP channel TRPM2 by the tyrosine phosphatase PTPL1.
Zhang W; Tong Q; Conrad K; Wozney J; Cheung JY; Miller BA
Am J Physiol Cell Physiol; 2007 May; 292(5):C1746-58. PubMed ID: 17251321
[TBL] [Abstract][Full Text] [Related]
49. Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor.
Ravichandran LV; Chen H; Li Y; Quon MJ
Mol Endocrinol; 2001 Oct; 15(10):1768-80. PubMed ID: 11579209
[TBL] [Abstract][Full Text] [Related]
50. X-ray crystal structure of the hypothetical phosphotyrosine phosphatase MDP-1 of the haloacid dehalogenase superfamily.
Peisach E; Selengut JD; Dunaway-Mariano D; Allen KN
Biochemistry; 2004 Oct; 43(40):12770-9. PubMed ID: 15461449
[TBL] [Abstract][Full Text] [Related]
51. Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules.
Rocchi S; Tartare-Deckert S; Murdaca J; Holgado-Madruga M; Wong AJ; Van Obberghen E
Mol Endocrinol; 1998 Jul; 12(7):914-23. PubMed ID: 9658397
[TBL] [Abstract][Full Text] [Related]
52. The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors.
Glover NR; Tracey AS
Biochem Cell Biol; 2000; 78(1):39-50. PubMed ID: 10735562
[TBL] [Abstract][Full Text] [Related]
53. Crystal structure of the catalytic domain of human MAP kinase phosphatase 5: structural insight into constitutively active phosphatase.
Jeong DG; Yoon TS; Kim JH; Shim MY; Jung SK; Son JH; Ryu SE; Kim SJ
J Mol Biol; 2006 Jul; 360(5):946-55. PubMed ID: 16806267
[TBL] [Abstract][Full Text] [Related]
54. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands.
Liu G; Xin Z; Liang H; Abad-Zapatero C; Hajduk PJ; Janowick DA; Szczepankiewicz BG; Pei Z; Hutchins CW; Ballaron SJ; Stashko MA; Lubben TH; Berg CE; Rondinone CM; Trevillyan JM; Jirousek MR
J Med Chem; 2003 Jul; 46(16):3437-40. PubMed ID: 12877578
[TBL] [Abstract][Full Text] [Related]
55. Acidic residues are involved in substrate recognition by two soluble protein tyrosine phosphatases, PTP-5 and rrbPTP-1.
Hippen KL; Jakes S; Richards J; Jena BP; Beck BL; Tabatabai LB; Ingebritsen TS
Biochemistry; 1993 Nov; 32(46):12405-12. PubMed ID: 8241130
[TBL] [Abstract][Full Text] [Related]
56. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
[TBL] [Abstract][Full Text] [Related]
57. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
58. The structure of the cell cycle protein Cdc14 reveals a proline-directed protein phosphatase.
Gray CH; Good VM; Tonks NK; Barford D
EMBO J; 2003 Jul; 22(14):3524-35. PubMed ID: 12853468
[TBL] [Abstract][Full Text] [Related]
59. Diverse levels of sequence selectivity and catalytic efficiency of protein-tyrosine phosphatases.
Selner NG; Luechapanichkul R; Chen X; Neel BG; Zhang ZY; Knapp S; Bell CE; Pei D
Biochemistry; 2014 Jan; 53(2):397-412. PubMed ID: 24359314
[TBL] [Abstract][Full Text] [Related]
60. Structural basis for inhibition of protein tyrosine phosphatases by Keggin compounds phosphomolybdate and phosphotungstate.
Heo YS; Ryu JM; Park SM; Park JH; Lee HC; Hwang KY; Kim J
Exp Mol Med; 2002 Jul; 34(3):211-23. PubMed ID: 12216113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
